1. Perfluorobutane contrast-enhanced ultrasonography for the diagnosis of HCC: a systematic review and meta-analysis
- Author
-
Jin Yan, Chengkai Liu, Yichun Yang, and Kebing Liu
- Subjects
medicine.medical_specialty ,Carcinoma, Hepatocellular ,Urology ,Contrast Media ,Sensitivity and Specificity ,Likelihood ratios in diagnostic testing ,030218 nuclear medicine & medical imaging ,03 medical and health sciences ,chemistry.chemical_compound ,0302 clinical medicine ,medicine ,Humans ,Radiology, Nuclear Medicine and imaging ,Ultrasonography ,Fluorocarbons ,Radiological and Ultrasound Technology ,medicine.diagnostic_test ,Perfluorobutane ,business.industry ,Liver Neoplasms ,Gastroenterology ,Reproducibility of Results ,Magnetic resonance imaging ,Publication bias ,Confidence interval ,Study heterogeneity ,chemistry ,030220 oncology & carcinogenesis ,Meta-analysis ,Radiology ,business ,Contrast-enhanced ultrasound - Abstract
Perfluorobutane ultrasound contrast agent as a new type of contrast agent has a good performance in the diagnosis of hepatocellular carcinoma (HCC). This study aim to evaluate the accuracy and reliability of Perfluorobutane contrast-enhanced ultrasonography (P-CEUS) in the diagnosis of HCC with a systematic review and meta-analysis. Web of Science, EMBASE, Cochrane, Clinical Key, Wan Fang, CBM and CNKI databases were systematically searched and checked for studies using P-CEUS in HCC, from 2007 to 2020. Data necessary to construct 2 × 2 contingency tables were extracted from included studies. The QUADAS tool was utilized to assess the methodologic quality of the studies. Meta-analysis included data pooling, subgroup analyses, meta-regression and investigation of publication bias was comprehensively performed. Nine studies were included in this meta-analysis and the overall diagnostic accuracy in characterization of HCC was as follows: pooled sensitivity, 0.90 (95% confidence interval: 0.82–0.95); pooled specificity, 0.97 (0.93–0.98); pooled positive likelihood ratio, 27.2 (14.1 to − 52.3); and pooled negative likelihood ratio, 0.10 (0.06–0.18). The area under the comprehensive receiving operation characteristic curve was 0.98 (0.97–0.99). The sensitivity and specificity of P-CEUS are more valuable than other imaging techniques (such as computer tomography or magnetic resonance imaging). However, due to the large differences in the data samples collected in this study, statistical heterogeneity results. P-CEUS can significantly improve the diagnostic efficiency of previous contrast-enhanced ultrasound for HCC. PROSPERO registration number: PROSPERO (CRD42020200040).
- Published
- 2021
- Full Text
- View/download PDF